Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Centene Corporation Common Stock (NY:CNC)

56.41 -1.66 (-2.86%)
Official Closing Price Updated: 7:00 PM EDT, May 23, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Centene Corporation Common Stock

< Previous 1 2
...
9 10 11 12 13 14 15 16 Next >
Knowing When To Sell A Stock: 15 Real-Life Examples To Guide Your Decision
If you realize and accept the reality that you cannot make perfect sell – or buy decisions for that matter, the decision becomes a lot less stressful and confusing. 
Via Talk Markets
This Analyst Is Bullish On Evolent Health's Recent Deal, Calls 'Highly Strategic Acquisition'
Via Benzinga
Centene Agrees To Divest Magellan Specialty Health To Evolent Health
Via Benzinga
Stock Market Rally Resilient As Apple Bucks Megacap Meltdown: Weekly Review
The Dow and S&P 500 moved above a key level while the Nasdaq rose. 
Via Investor's Business Daily
Centene (CNC) Q3 2022 Earnings Call Transcript
CNC earnings call for the period ending September 30, 2022. 
Via The Motley Fool
Centene Shares Pop On Q3 Beat, Lifts Annual Revenue Guidance
Via Benzinga
Earnings Scheduled For October 25, 2022
Companies Reporting Before The Bell • UBS Gr (NYSE:UBS) is expected to report earnings for its third quarter. • SAP (NYSE:SAP) is expected to report earnings for its third quarter. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 13, 2022
Via Benzinga
Why Evolent Health Stock Is Soaring Today
Investors are applauding Evolent's latest acquisition. 
Via The Motley Fool
Where Centene Stands With Analysts
Within the last quarter, Centene (NYSE:CNC) has observed the following analyst ratings: 
Via Benzinga
What 7 Analyst Ratings Have To Say About Centene
Centene (NYSE:CNC) has observed the following analyst ratings within the last quarter: 
Via Benzinga
Midterm Elections 2022: 3 Stocks to Avoid Like the Plague for a ‘Red Wave’
If you see a red wave coming, here are three stocks to avoid in sectors that are unlikely to perform well under a Republican majority. 
Via InvestorPlace
Looking Into Centene's Return On Capital Employed
According to Benzinga Pro, during Q3, Centene (NYSE:CNC) earned $740.00 million, a 532.75% increase from the preceding quarter. Centene's sales decreased to $35.87 billion, a 0.2% change since Q2. 
Via Benzinga
This Foreboding Sign Looms Over Centene's Chart
If history is any guide, there may be trouble ahead for shares of Centene (NYSE:CNC). A so-called "death cross" has formed on its chart and, not surprisingly, this could be bearish for the stock. 
Via Benzinga
Peering Into Centene's Recent Short Interest
Centene's (NYSE:CNC) short percent of float has fallen 9.44% since its last report. The company recently reported that it has 8.29 million shares sold short, which is 1.63% of all regular shares that... 
Via Benzinga
Recap: Centene Q3 Earnings
Centene (NYSE:CNC) reported its Q3 earnings results on Tuesday, October 25, 2022 at 06:00 AM. Here's what investors need to know about the announcement. Earnings Centene beat estimated earnings by... 
Via Benzinga
Here's How Much You Would Have Made Owning Centene Stock In The Last 15 Years
Centene (NYSE:CNC) has outperformed the market over the past 15 years by 12.45% on an annualized basis producing an average annual return of 18.69%. Currently, Centene has a market capitalization of... 
Via Benzinga
Can Molina Healthcare Sustain Its Market-Beating Rally?
While bigger industry peers get more attention, large-cap managed-care provider Molina shows better price strength as well as solid earnings and revenue growth. 
Via MarketBeat
Topics ETFs
UNH Stock: UnitedHealth Earnings On Deck, With Dow Jones Giant Holding Key Support
UnitedHealth will kick off health insurers' third-quarter results Friday morning. 
Via Investor's Business Daily
A Congressman Just Sold JPMorgan Stock Ahead Of Earnings: See Two Dividend Stocks He Is Also Trading
Congressman Earl Blumenauer (D-Ore.) has served as the U.S. Representative for Oregon's 3rd congressional district since 1996. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 30, 2022
Upgrades 
Via Benzinga
Neurocrine Leads 5 Stocks To Watch In Sickly Market
Neurocrine Biosciences leads five medical stocks showing resilience. 
Via Investor's Business Daily
Benzinga's Top Ratings Upgrades, Downgrades For August 26, 2022
Upgrades 
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
5 Strong Uptrend Stocks to Buy on the Next Dip
In a bear market, not many strong uptrend stocks can be found. But if you're patient, they'll eventually come. Here are five to watch now. 
Via InvestorPlace
Are Medtronic And Intuitive Surgical Poised For Big Growth?
Health care is one of the better-performing sectors in 2022, with medical gear makers Medtronic and Intuitive Surgical outpacing the broader industry recently. 
Via MarketBeat
Topics ETFs
Exposures COVID-19
'I Think It's Too Cheap To Get Rid Of': Jim Cramer Recommends Holding Onto This Stock
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Lions Gate Entertainment Corp (NYSE: LGF-A) is a "value trap." He added, "While it makes money, it’s not what this market wants." 
Via Benzinga
Looking Into Centene's Recent Short Interest
Centene's (NYSE:CNC) short percent of float has fallen 14.67% since its last report. The company recently reported that it has 7.35 million shares sold short, which is 1.28% of... 
Via Benzinga
Here's How Much $1000 Invested In Centene 15 Years Ago Would Be Worth Today
Centene (NYSE:CNC) has outperformed the market over the past 15 years by 13.95% on an annualized basis producing an average annual return of 21.12%. Currently, Centene has a market capitalization of... 
Via Benzinga
Centene's Return On Capital Employed Overview
Benzinga Pro data, Centene (NYSE:CNC) reported Q2 sales of $35.94 billion. Earnings fell to a loss of $171.00 million, resulting in a 120.07% decrease from last quarter. Centene earned $852.00 million,... 
Via Benzinga
< Previous 1 2
...
9 10 11 12 13 14 15 16 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.